A Broad Analysis of the “Worldwide Molecular Diagnostics Market “methodology of the leading organizations in the exactness of import/export utilization, Industry activity figures, cost, value, revenue and gross edges.
Molecular Diagnostics Market – Highlights
A necessary part of in-vitro diagnostics, molecular diagnostics a collection of techniques useful for analyzing biomarkers in genomics and proteomics.
Market Research Future (MRFR) has published a research report about the global molecular diagnostics market that envisions prosperity for this market at 9.6% CAGR (Compound Annual Growth Rate) during the forecast period between 2017 and 2023.
TRY PREMIUM SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/1171
Leading Key Players
The key players in the global molecular diagnostics market include Abbott (USA), Beckman Coulter Inc. (USA), Becton, Dickinson & Company (BD) (USA), bioMérieux SA (France), Bio-Rad Laboratories Inc. (USA), Cepheid (USA), Grifols (Spain), Hoffmann-La Roche Ltd. (USA), Hologic, Inc. (USA), QIAGEN N.V. (the Netherlands), and Siemens Healthcare GmbH (Germany).
Molecular Diagnostics Market – Growth and Analysis
The key factors that support the growth of the global molecular diagnostics market include the advancement in molecular techniques and the increasing prevalence of infectious diseases and various types of cancer.
The Polymerase chain reaction (PCR) technology is also aiding the market growth for molecular diagnostics. Molecular diagnostics includes automated and easy-to-handle techniques. However, the high price of diagnostics kits can be hurdles in the market growth during the forecast period.
Detailed Market Segmentation
The global molecular diagnostics market has been segmented on the basis of applications, end users, techniques, and lastly, region. As per application, this market has been segmented into blood screening, coagulation, genetic testing, human leukocyte antigen typing, infectious diseases, oncology, pharmacogenomics, and others.
Based on end users, the market has been segmented into academics & research institutions, diagnostic laboratories, and hospitals. On the basis of techniques, the market has been segmented into fluorescence in-situ hybridization, microarray, PCR & real-time PCR, and transcription-mediated amplification.
Molecular Diagnostics Market – Regional Analysis
Other reasons for market growth are high healthcare spending, increasing government support for research & development (R&D), the concentration of major companies on molecular diagnostics due to increased R&D, increasing patient with bone disorders, and well-developed technology.
Due to technological advancement and the availability of advanced medical facilities, North America is the bigger market over South America. In North America, the USA and Canada are the most important country-specific markets.
Many key market players are based in North America, especially in the USA. In South America, Argentina and Brazil are two strong economies that have the potential to grow as suitable markets.
Europe is the second most valuable regional market, followed by the Asia Pacific region. In Europe, the reasons for the market growth are the increasing number of private diagnostic centers and increasing prevalence of lifestyle and chronic diseases.
OBTAIN PREMIUM RESEARCH REPORT DETAILS @ https://www.marketresearchfuture.com/reports/molecular-diagnostics-market-1171
The major country-specific markets in Europe are France, Germany, Italy, Spain, and the UK, followed by the remaining countries of Western Europe and Eastern Europe.
In the Asia Pacific region, China has the highest number of cancer deaths. The second highest number is in South Korea. In this region, apart from a high number of cancer deaths, some other factors contributing to the market growth are increasing demand for quality devices in the healthcare and use of advanced equipment.
Other country-specific markets in this region are Australia, India, and Japan, followed by the remaining countries of the Asia Pacific region.
On the other hand, in the MEA region, blood disorders have become a huge problem due to ignorance of diseases, limited screening, and poor access to treatment. Therefore, the market in this region is small, but it does exist. The most important country-specific markets in this region are Kuwait, Oman, Qatar, and Saudi Arabia, followed by the other countries in the MEA region.
Latest Industry News
- CIRCULOGENE, advancing precision medicine through molecular genetics testing, has forged an international partnership with New Zealand-based CIRCULOGENE Asia Pacific Limited. 3 JAN 2019
- In order to help clinical laboratories deliver accurate results during cold and flu season, Microbiologics Inc. has launched two new panels for quality control of Group a Streptococcus (GAS) and respiratory molecular assays and test methods. 13 DEC 2018
Some Points form Table of Content
1.2 Scope of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.3 Market Structure
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.4 Macroeconomic Indicators
GET EXCUSIVE DISCOUNT @ https://www.marketresearchfuture.com/check-discount/1171
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Phone: +1 646 845 9312